Member Info for Valuerebel

In the Spinnaker Prospectus..

RTO Warrants
As announced on 15 June 2020, the warrants that were issued to IPO subscribers on 17 May 2017 expired ?on 17 May 2020. With the consent of Kanabo the board intends to issue, subject to Admission, fresh warrants to shareholders on the register at the time of this announcement. Pursuant to a warrant instrument, the Company shall, conditional on Admission, grant a warrant over one new Ordinary Share for every two Ordinary Shares. The warrants granted under the terms of the RTO Warrant Instrument shall be exercisable in the period commencing on the date of Admission until the date 12 months after the date of Admission. The warrants shall be exercisable at 10 pence per Ordinary Share.

robsaunders. I don't disagree that Kanabo should do well on listing. However other comparisons of note between MXC and Kanabo include:
1/ £6MM worth of shares issued via two brokers Peterhouse and SI Capital. There will be plenty of free float on issue. Brokers get given extra shares as a reward for market making so they will be out there for grabs on day 1. Same as for MXC on Tuesday.
2/ Looks like Kanabo is issuing 1 for 2 warrants exercisable at 10p. There were no warrants issued to placees in MXC. Once Kanabo gets over 10p then like other recent placements that have taken off (OMI for example ) the warrant holders might sell their underlying shares knowing they have their warrants in place like free options. That provides some supply above 10p.

Kevijoh . What is your end valuation for this stock and why?

Donato84 To help you out the MCAP at 4.05 is £73MM which is still half the ZOE MCAP.

Unpleasant 14% rise in the share price today.
Untill further news and with billions of shares at 0.1p being sold, Can only see this going lower.

One or two people here have been questioning the current MCAP of MXC (now £68MM)and saying look out for newer placings which I presume they mean Kanabo coming next week 16th and Cellular Goods backed by David Beckham. When i compare these three companies they are focusing on slightly different areas of CBD . Cellular Goods said "it will be the first LSE-listed 'pure-play' consumer cannabinoid brands company. Its CBD products are focused on skincare and athletic recovery. The company, which said it is eyeing a listing in Spring, plans to raise GBP8 million in its initial public offering." My concern with this is share is that many got in pre-IPO as was the case with ARB (ARGO Blockchain) when it first came to market , there's nothing to stop hefty backers just cashing out in the first week of trading. Kanabo seems like a good company and seems to focus on sleep disorders amongst other things. Vega just invested £150k in this company in the current shell Spinnaker Opportunities putting a valuation of £20MM MCAP on Kanabo. The share placing coming may well put a higher valuation on this . MGC Pharma focus on different angles as we will hear in the proactive interview tomorrow. They are looking at products for Alzheimer's, Dementia, Cerebral Palsy and they have a Covid 19 angle to boot. I apologise if I am oversimplifying things here but in summary there is a different focus between the companies. I personally believe that MGC and Kanabo have bright futures as far SP percentage increases are concerned but will be a bit careful on Cellular Goods from the beginning. There is room for many of these companies over the next few years in an investment portfolio IMHO. Comments welcome...

EliteTrader..you are making stuff up now. They have existing products that are making revenues already . Breakeven forecast for 2H 2021 . As for a valuation , how can ZOE be worth £155MM with limited sales and TW on their back when this was a third of that valuation last night? This also has a Covid 19 slant having done phase 2 trials. There are plenty more product launches to come, you have the advantage of being first mover attracting capital ahead of Kanabo on 16th February and whatever the overhyped Beckham business is endorsing. There is room for many CBD plays in Europe and this is the first medical one so plenty of upside still IMHO.

I am looking for 8p or a MCAP of £150MM which puts it on the same level as ZOE at a minimum . If the Level 3 trials go as expected and there is expansion of revenue exponentially I would double that target .

pumpky . I was a placee and was massively scaled back so bought more yesterday at 2.5p. Why would we want to sell at this level? MCAP is 1/3 rd of Zoetic in a breakeven business without the accounting issues.

You mentioned TW the other day. He's busy counting his pennies after his AEXG purchase and recommendation at 57p isn't he (down 42% today) ?

Go back to Crypto land Robin.

GB Good retort and Top Man. Have been trying to defend the non-believers on here..

Chesh . I don't care, she sleeps with greatness.

MCAP of MXC just over £48MM with annual sales compared with ZOE MCAP at £150MM with minimum sales and TW on their back about accounts.

That's Crap..EUR500K or GBP 439,000 of assets

cornish..You have to fulfill two kof these three criteria: 1/ Over EUR500MM of investable assets anywhere. 2/ Have worked in a financial institution for more than a year. 3/ Trade at least 4 times a month.

Everyone has an opinion and that's fine just I wonder why you think it will retrace. Saying all Placings retrace to a discounted placing price is simply not true. Look at UFO last year, IRON, OMI. If they are done at a cheap enough level then that doesn't happen. The business structure and funding now is very different to what it was two months ago, with a new set of shareholders holding the bulk of the company including new Institutional money who will back GB. Also TP work on the basis that if you flip a placing immediately you won't get invited back to any more. The bulk of the TP investors (including me) have been through Integumen, Modern Water and DVRG placings with GB and know what we are getting. There won't be significant sellers of this placing from the off.

I'm a placee milking a healthy profit and i bought more at 0.25 . I think it has legs ..no interest in taking any quick buck. If you knew how TP worked then you wouldn't be making such comments.

Whirlaw..bought 1/3 of what I ideally want..will wait on news in case we dip again. I have been watching this one for a while and this is just a gift down here IMHO. If they need some more cash (they have a lot anyway) then I can put in more. I think at high 50's it was a mild risk, here it's just a question of time.

Dysonv12. 1 post wonder. Odd this is your first post ever on LSE? An experienced investor coming on board and this is your first ever LSE post..do you get paid to decamp by any chance?